Renalytix PLC
LSE:RENX
Cash Flow Statement
Cash Flow Statement
Renalytix PLC
Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||
Net Income |
(11)
|
(21)
|
(36)
|
(46)
|
(50)
|
(45)
|
(46)
|
|
Depreciation & Amortization |
1
|
1
|
2
|
3
|
3
|
3
|
2
|
|
Other Non-Cash Items |
(0)
|
(3)
|
6
|
8
|
1
|
2
|
5
|
|
Cash Interest Paid |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
(1)
|
(1)
|
3
|
2
|
0
|
5
|
6
|
|
Cash from Operating Activities |
(10)
N/A
|
(22)
-121%
|
(25)
-11%
|
(34)
-37%
|
(46)
-35%
|
(36)
+21%
|
(33)
+9%
|
|
Investing Cash Flow | ||||||||
Capital Expenditures |
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
0
|
|
Other Items |
1
|
10
|
1
|
(0)
|
0
|
(0)
|
0
|
|
Cash from Investing Activities |
(0)
N/A
|
9
N/A
|
(1)
N/A
|
(1)
-36%
|
(1)
+31%
|
(0)
+83%
|
0
N/A
|
|
Financing Cash Flow | ||||||||
Net Issuance of Common Stock |
16
|
79
|
77
|
(2)
|
9
|
9
|
20
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
18
|
16
|
(4)
|
|
Other |
0
|
(2)
|
0
|
2
|
(2)
|
(2)
|
(0)
|
|
Cash from Financing Activities |
17
N/A
|
77
+367%
|
77
0%
|
1
-99%
|
26
+3 976%
|
24
-7%
|
15
-36%
|
|
Change in Cash | ||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
(3)
|
(4)
|
1
|
|
Net Change in Cash |
6
N/A
|
64
+961%
|
52
-18%
|
(35)
N/A
|
(24)
+31%
|
(16)
+32%
|
(17)
-3%
|
|
Free Cash Flow | ||||||||
Free Cash Flow |
(11)
N/A
|
(24)
-109%
|
(26)
-10%
|
(35)
-32%
|
(46)
-34%
|
(36)
+22%
|
(33)
+9%
|